Please login to the form below

Not currently logged in
Email:
Password:

Lucid Group acquires digital and creative agency Bluedog

The move comes as the group celebrates its 12-year anniversary

Steele, Horn and O'Brien

Celebrations are in full swing for Lucid Group today after it announced it has bought London-based digital and creative agency Bluedog.

Bluedog brings a “key piece of the jigsaw” to Lucid, commented Lucid’s CEO Dennis O’Brien, referring to the company’s skills in digital design, motion graphics, video development and web design.

The company has been producing a range of materials for clients such as Takeda, Eisai and Merck Sharp & Dohme for over 23 years; a key factor that makes the new partnership a “perfect match” says O’Brien.

He adds: “We have developed a reputation for excellent content and scientific storytelling and Bluedog’s talent and capability will be instrumental in enhancing our audience reach and engagement, helping transform lives.”

Bluedog is the group’s first major acquisition, and it will build on Lucid’s offering, which spans across four other independent consultancies (Leading Edge, Lighthouse, Lucid Partners and Vivid).

Nigel Horn, Bluedog Managing Director commented, “I am delighted that Bluedog is joining Lucid Group. With our strongest ever year in 2018, this is a good time for Bluedog to establish itself as a leader in digital design and delivery. The partnership with Lucid Group will enable us to do this”

The move comes as the group celebrates its 12-year anniversary, and Lucid Group has confirmed that it has ambitions to further broaden its capability with the support of its private equity partner LDC.

Article by
Gemma Jones

14th February 2019

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics